ADL BIONATUR SOLUTIONS

Trading sesion


09/08/2022 Close

0.1958

Last price


9.53 mill. €

Capitalisation

0.00

Dif.(%)


-57.34

% Year 2022

Last Trade

Date

09/08/2022

Hour

Close

Last

0.1958

Ref.

0.1958

Dif.(%)

0.00

Volume (Shares)

8,777

Turnover (€x1000)

1.68

X
09/08/2022 17:37:24
BidAsk
OrdersVolumePricePriceVolumeOrders
212,5090.19000.19588,3411

Security

Security name

ADL BIONATUR SOLUTIONS

Ticker

ADL

ISIN

ES0184980003

NIF

A-11811163

Shares Admitted

48.690.242

Nominal

0,05 Euros

Capital Admitted

2.434.512,10 Euros

Trading

Continuo

Liquidity Provider

AURIGA GLOBAL INVESTORS S.V., S.A.

Registered Advisor

IMPULSA CAPITAL S.L.

Auditor

AUREN AUDITORES, S.L.

Address

AV DESARROLLO TECNOLOGICO 11, JEREZ DE LA FRONTERA

Contact

ir@adlbionatur.com

Historical Summary

 20182019202020212022 until 9/08

Capital Admitted (thousands of euros)

1,9691,9691,9692,2922,435

Shares (x 1,000)

39,38939,38939,38945,83348,690

Period Close Price (euros)

1.67002.04000.55600.45900.1958

Period Last Price (euros)

1.67002.04000.55600.45900.1958

Period High Price (euros)

3.68002.50002.28001.08500.5360

Period Low Price (euros)

1.58001.63000.35000.43300.1632

Capitalisation (thousands of euros)

65,78080,35421,90021,0379,534

Volume (thousands of shares)

2,7133,69825,81086,51825,150

Turnover (thousands of euros)

6,2357,75916,05960,5588,830

Company Profile

ADL Bionatur is a biotechnology group strategically focused on the ‘One Health’ concept which encompasses human and animal health. Subsidiaries and a global commercial structure devoted to the monetisation of their different high-valued assets. Depending on their field of application, these assets can be categorised as follows: 1) detection / diagnosis, 2) prevention, 3) therapeutic, 4) fermentation ingredients.
 
The Group's main strategy is to foster its commercial network in order to leverage the organic growth of its assets while evaluating opportunities of inorganic growth in the biotechnology field.

Inside Information

Other Relevant Information

Notices

Relevant Facts until 10/05/2020

Significant participations

Financial Reports

Photo Gallery

To obtain detailed information or information in other formats, please contact BME Market Data at marketdata@grupobme.es or visit the website www.bmemarketdata.es.

The information provided by the different websites of Grupo BME is for internal use only. For any commercial use and/or other usage that involves the redistribution of the information to third parties for a fee, it is required a prior and express permission from BME Market Data. Please contact us at marketdata@grupobme.es.